Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GT Biopharma, Inc.GTBP · Entity 7878 | Former Officer and Director | December 21, 2020 | December 23, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GT Biopharma, Inc.
Report date December 21, 2020 · Filed December 23, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,720,000 |
Ending reported balance
After 2020-12-22 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2020-12-21 · Sale · Disposed 50,000 · Balance 3,853,700 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Row 2 · 2020-12-21 · Sale · Disposed 50,000 · Balance 3,803,700 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Row 3 · 2020-12-21 · Sale · Disposed 35,722 · Balance 3,767,978 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Row 4 · 2020-12-22 · Sale · Disposed 47,978 · Balance 3,720,000 F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2020 Filed Dec 23, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 47,978 | $0.40 | $19,191.20 |
DisclosureSEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 4 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,720,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 35,722 | $0.34 | $12,145.48 |
DisclosureSEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 3 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,767,978 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.33 | $16,500.00 |
DisclosureSEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 2 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,803,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 21, 2020 Filed Dec 23, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000003 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,853,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 18, 2020 Filed Dec 18, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000002 · primary_doc.xml · nonDerivative · entry 4 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,903,700 F1 · kind: . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.31 | $15,500.00 |
DisclosureSEC source: 0001356710-20-000002 · primary_doc.xml · nonDerivative · entry 3 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,953,700 F1 · kind: . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 17, 2020 Filed Dec 18, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000002 · primary_doc.xml · nonDerivative · entry 2 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,003,700 F1 · kind: . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 16, 2020 Filed Dec 18, 2020 21:24 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000002 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,053,700 F1 · kind: . The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 15, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.32 | $16,000.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 8 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,103,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 15, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 7 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,153,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 15, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.30 | $15,000.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 6 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,203,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 46,300 | $0.29 | $13,427.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 5 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,253,700 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.29 | $14,500.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 4 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 14, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.28 | $14,000.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 3 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,350,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.26 | $13,000.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 2 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| December 11, 2020 Filed Dec 15, 2020 22:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | SaleCommon Stock | 50,000 | $0.25 | $12,500.00 |
DisclosureSEC source: 0001356710-20-000001 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Former Officer and Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,450,000 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020. Read SEC document |
| May 13, 2020 Filed May 14, 2020 17:40 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Salecommon stock | 2,269,708 | $0.00 | $2,269.71 |
DisclosureSEC source: 0000939798-20-000006 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Director · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,500,000 F1 · shares: The disposal of the 2,269,708 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 20:51 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Grantcommon stock | 4,500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-19-000030 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Director · CFO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,769,707 Read SEC document |
| September 01, 2017 Filed Dec 1, 2017 22:17 UTC | GT Biopharma, Inc. GTBP · Entity 7878 | Grantcommon stock | 2,566,835 | $0.00 | $0.00 |
DisclosureSEC source: 0000939798-17-000099 · primary_doc.xml · nonDerivative · entry 1 Weldon Steven W · CIK 0001356710 · Director · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,568,840 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.